enzastaurin has been researched along with Thyroid Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkmann, J; Hanauske, A; Lahn, M; Ohnmacht, U; Smetak, M; Weigang-Koehler, K; Wilhelm, M | 1 |
| Bondanelli, M; degli Uberti, EC; Filieri, C; Gagliano, T; Gentilin, E; Molè, D; Pansini, G; Pelizzo, MR; Rossi, M; Tagliati, F; Zatelli, MC | 1 |
| Blatter, J; Eismann, U; Hanauske, AR; Lahn, MM; Ma, D; Oberschmidt, O; Schulz, L; Struck, S | 1 |
3 other study(ies) available for enzastaurin and Thyroid Neoplasms
| Article | Year |
|---|---|
Reduction of HLA-DR+ lymphocytes after treatment with enzastaurin in patients with metastatic thyroid cancer.
Topics: Antineoplastic Agents; HLA-DR Antigens; Humans; Immunophenotyping; Indoles; Lymphocyte Count; Lymphocytes; Neoplasm Metastasis; Thyroid Neoplasms | 2008 |
Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro.
Topics: Adult; Aged; Apoptosis; Carcinoma, Medullary; Cell Line, Tumor; Cell Proliferation; Female; Humans; Indoles; Male; Middle Aged; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Thyroid Gland; Thyroid Neoplasms | 2012 |
Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Folic Acid Antagonists; Glutamates; Guanine; Humans; Indoles; Pemetrexed; Protein Kinase C; Protein Kinase C beta; Thyroid Neoplasms | 2005 |